CD33 and early-onset autosomal dominant Alzheimer disease: This interaction was found to be elevated in Alzheimer’s disease patients and correlated with greater pathological burden, thereby establishing a functional SIGLEC3-CD45 sialoglycan axis implicated in Alzheimer’s disease pathogenesis.